To identify the effect of ERK2 SUMOylation on breast cancer cells, we constructed rescued stable MDA-MB-231 cells by lentiviral transduction of ERK2 knockdown cells with wild-type or SUMO site mutant ERK2 plasmids that were resistant to ERK2 shRNA. This evidence concerns the gene MAPK1 and breast carcinoma.